| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5510171 | Clinical Biochemistry | 2017 | 7 Pages |
Abstract
In patients presenting with an ACS and treated with percutaneous coronary intervention, elevated AP activity is associated with increased risk of subsequent mortality.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Gjin Ndrepepa, Stefan Holdenrieder, Erion Xhepa, Salvatore Cassese, Massimiliano Fusaro, Karl-Ludwig Laugwitz, Heribert Schunkert, Adnan Kastrati,